by Minomic | Sep 29, 2021
Shared CLIA lab to help diagnostics start-ups, including Australian-based Minomic,more rapidly enter the U.S. market Rockville, MD, September 28, 2021 – 20/20 GeneSystems, Inc., (“20/20”), announced the launch of its Clinical Lab Innovation Axcellerator (CLIAx),...
by Minomic | Apr 20, 2021
Sydney, April 20, 2021: GloriousMed Biomedical Group Co., Ltd (“GloriousMed”) and Minomic International Ltd (“Minomic”) of Australia officially executed the agreement, which formally launched the commercialization of MiCheck® Prostate, a...
by Minomic | Feb 11, 2021
At Minomic, we are proud to be part of the NSW Going Global Export Program, a NSW Government funded export assistance package, designed to boost NSW exports and unlock international markets for sustainable businesses following the impacts of COVID-19, the bushfires...
by Minomic | Jun 17, 2020
Explore the impact of the pandemic lockdown on medtech, biotech and pharma sectors in Australia by downloading MTPConnect’s COVID-19 Impact...
